Issue 14, 2012

Precise control of intracellular drug release and anti-tumor activity of biodegradable micellar drugsvia reduction-sensitive shell-shedding

Abstract

The reduction-sensitive shedding of hydrophilic shells has recently emerged as a simple, effective and general approach to achieve markedly improved intracellular drug release from micelles. Here, the effects of disulfide content on reduction-sensitivity, triggered drug release and the anti-tumor activity of shell-sheddable micelles self-assembled from a mixture of reducible poly(ethylene glycol)–SS–poly(ε-caprolactone) (PEG–SS–PCL) and non-reducible poly(ethylene glycol)–poly(ε-caprolactone) (PEG–PCL) block copolymers were systematically investigated. Interestingly, in contrast to the rapid aggregation of PEG–SS–PCL micelles, mixed micelles containing 10–90 wt% PEG–PCL displayed little size change in response to 10 mM dithiothreitol (DTT). The in vitro release studies showed that under intracellular-mimicking reductive environments, the doxorubicin (DOX) release rate increased with increasing PEG–SS–PCL content in the micelles, in which about 29.4, 42.7, 77.9 and 86.9% DOX was released within 12 h from micelles containing 30, 50, 70 and 90 wt% PEG–SS–PCL, respectively. In contrast, DOX release was limited (<20%) under non-reductive physiological conditions. Notably, flow cytometry displayed clear correlation between cellular DOX levels and PEG–SS–PCL content in DOX-loaded micelles. Moreover, confocal laser scanning microscopy (CLSM) observations indicated progressively stronger DOX fluorescence in RAW 264.7 cells following 12 h treatment with DOX-loaded micelles containing increasing PEG–SS–PCL contents. In addition, MTT assays in RAW 264.7 cells showed that the cytotoxicity of DOX-loaded micelles was augmented proportionally to PEG–SS–PCL content, signifying the role of reduction-triggered “active” drug release in cells. These results have shown that the intracellular drug release and therefore anti-tumor activity of micellar drugs can be precisely controlled by the extent of reduction-triggered shedding of hydrophilic shells.

Graphical abstract: Precise control of intracellular drug release and anti-tumor activity of biodegradable micellar drugs via reduction-sensitive shell-shedding

Article information

Article type
Paper
Submitted
24 Dec 2011
Accepted
03 Feb 2012
First published
28 Feb 2012

Soft Matter, 2012,8, 3949-3956

Precise control of intracellular drug release and anti-tumor activity of biodegradable micellar drugs via reduction-sensitive shell-shedding

W. Wang, H. Sun, F. Meng, S. Ma, H. Liu and Z. Zhong, Soft Matter, 2012, 8, 3949 DOI: 10.1039/C2SM07461C

To request permission to reproduce material from this article, please go to the Copyright Clearance Center request page.

If you are an author contributing to an RSC publication, you do not need to request permission provided correct acknowledgement is given.

If you are the author of this article, you do not need to request permission to reproduce figures and diagrams provided correct acknowledgement is given. If you want to reproduce the whole article in a third-party publication (excluding your thesis/dissertation for which permission is not required) please go to the Copyright Clearance Center request page.

Read more about how to correctly acknowledge RSC content.

Social activity

Spotlight

Advertisements